Kiniksa [KNSA] vs Zoetis [ZTS] Detailed Stock Comparison
Kiniksa
NASDAQ
Loading...
Zoetis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kiniksa wins in 6 metrics, Zoetis wins in 13 metrics, with 0 ties. Zoetis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kiniksa | Zoetis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 662.20 | 27.31 | Zoetis |
| Price-to-Book Ratio | 4.95 | 14.58 | Kiniksa |
| Debt-to-Equity Ratio | 1.97 | 145.63 | Kiniksa |
| PEG Ratio | 60.20 | 23.99 | Zoetis |
| EV/EBITDA | 360.66 | 18.82 | Zoetis |
| Profit Margin (TTM) | 0.90% | 27.12% | Zoetis |
| Operating Margin (TTM) | 12.86% | 38.11% | Zoetis |
| EBITDA Margin (TTM) | 12.86% | 38.11% | Zoetis |
| Return on Equity | 1.03% | 52.09% | Zoetis |
| Return on Assets (TTM) | 0.47% | 15.11% | Zoetis |
| Free Cash Flow (TTM) | $25.41M | $2.30B | Zoetis |
| Dividend Yield | N/A | 1.11% | N/A |
| 1-Year Return | 27.73% | -18.39% | Kiniksa |
| Price-to-Sales Ratio (TTM) | 4.58 | 7.29 | Kiniksa |
| Enterprise Value | $2.16B | $72.76B | Zoetis |
| EV/Revenue Ratio | 4.07 | 7.84 | Kiniksa |
| Gross Profit Margin (TTM) | 54.71% | 71.98% | Zoetis |
| Revenue per Share (TTM) | $7 | $21 | Zoetis |
| Earnings per Share (Diluted) | $0.05 | $5.57 | Zoetis |
| Beta (Stock Volatility) | 0.13 | 0.91 | Kiniksa |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Kiniksa vs Zoetis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kiniksa | -2.90% | 0.53% | 18.16% | 20.32% | 64.03% | 61.23% |
| Zoetis | 1.51% | -3.12% | -7.42% | -5.31% | -14.28% | -9.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kiniksa | 27.73% | 159.07% | 81.64% | 65.64% | 65.64% | 65.64% |
| Zoetis | -18.39% | -15.59% | -7.24% | 205.07% | 375.27% | 375.27% |
Performance & Financial Health Analysis: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.42B | $67.73B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 928,110 | 3,477,390 |
| 90 Day Avg. Volume | 965,837 | 3,122,150 |
| Last Close | $32.15 | $167.10 |
| 52 Week Range | $17.82 - $33.98 | $139.70 - $200.33 |
| % from 52W High | -5.39% | -16.59% |
| All-Time High | $33.98 (Aug 05, 2025) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -5.39% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.44% | 0.01% |
| Quarterly Earnings Growth | 0.44% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.27% |
| Operating Margin (TTM) | 0.13% | 0.38% |
| Return on Equity (TTM) | 0.01% | 0.52% |
| Debt to Equity (MRQ) | 1.97 | 145.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.69 | $10.44 |
| Cash per Share (MRQ) | $4.15 | $3.91 |
| Operating Cash Flow (TTM) | $66.95M | $2.94B |
| Levered Free Cash Flow (TTM) | $39.42M | $2.30B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.11% |
| Last 12-Month Dividend | N/A | $1.86 |
Valuation & Enterprise Metrics Analysis: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 662.20 | 27.31 |
| Forward P/E | 60.20 | 23.99 |
| PEG Ratio | 60.20 | 23.99 |
| Price to Sales (TTM) | 4.58 | 7.29 |
| Price to Book (MRQ) | 4.95 | 14.58 |
| Market Capitalization | ||
| Market Capitalization | $2.42B | $67.73B |
| Enterprise Value | $2.16B | $72.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.07 | 7.84 |
| Enterprise to EBITDA | 360.66 | 18.82 |
| Risk & Other Metrics | ||
| Beta | 0.13 | 0.91 |
| Book Value per Share (MRQ) | $6.69 | $10.44 |
Financial Statements Comparison: Kiniksa vs Zoetis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Revenue/Sales | $137.79M | $2.22B |
| Cost of Goods Sold | $61.66M | $622.00M |
| Gross Profit | $76.13M | $1.60B |
| Research & Development | $19.33M | $157.00M |
| Operating Income (EBIT) | $13.27M | $846.00M |
| EBITDA | $13.62M | $991.00M |
| Pre-Tax Income | $15.57M | $810.00M |
| Income Tax | $7.03M | $179.00M |
| Net Income (Profit) | $8.54M | $631.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Cash & Equivalents | $157.13M | $1.72B |
| Total Current Assets | $355.91M | $5.88B |
| Total Current Liabilities | $97.27M | $3.39B |
| Long-Term Debt | $7.62M | $5.40B |
| Total Shareholders Equity | $457.49M | $4.66B |
| Retained Earnings | $-512.60M | $12.38B |
| Property, Plant & Equipment | $14.20M | $6.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KNSA | ZTS |
|---|---|---|
| Operating Cash Flow | $30.98M | $567.00M |
| Capital Expenditures | $-99,000 | N/A |
| Free Cash Flow | $22.23M | $438.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-412,000 | $-443.00M |
Short Interest & Institutional Ownership Analysis
| Metric | KNSA | ZTS |
|---|---|---|
| Shares Short | 2.53M | 7.85M |
| Short Ratio | 2.48 | 2.67 |
| Short % of Float | 0.06% | 0.02% |
| Average Daily Volume (10 Day) | 928,110 | 3,477,390 |
| Average Daily Volume (90 Day) | 965,837 | 3,122,150 |
| Shares Outstanding | 72.52M | 448.47M |
| Float Shares | 33.51M | 444.39M |
| % Held by Insiders | 0.04% | 0.00% |
| % Held by Institutions | 0.95% | 0.96% |
Dividend Analysis & Yield Comparison: Kiniksa vs Zoetis
| Metric | KNSA | ZTS |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.86 |
| Last 12-Month Dividend Yield | N/A | 1.11% |
| 3-Year Avg Annual Dividend | N/A | $1.63 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $4.90 |
| Ex-Dividend Date | N/A | Apr 21, 2025 |